12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
- Novo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 23.5% to $0.14 during Tuesday's after-market session. This security traded at a volume of 29.7 million shares come close, making up 590.5% of its average volume over the last 100 days. The company's market cap stands at $21.2 million.
- Nexalin Technology (NASDAQ:NXL) stock increased by 17.82% to $0.72. The market value of their outstanding shares is at $5.2 million. As per the news, the Q2 earnings report came out 3 days ago.
- T2 Biosystems (NASDAQ:TTOO) shares moved upwards by 14.7% to $0.68. Today's trading volume for this security ended up closing at 38.1 million shares, which is 43.5 percent of its average volume over the last 100 days. The company's market cap stands at $226.1 million.
- MSP Recovery (NASDAQ:LIFW) shares moved upwards by 14.19% to $0.14. This security traded at a volume of 921.3K shares come close, making up 323.6% of its average volume over the last 100 days. The company's market cap stands at $45.3 million.
- Alzamend Neuro (NASDAQ:ALZN) stock increased by 7.73% to $0.33. The market value of their outstanding shares is at $31.8 million.
- Tenon Medical (NASDAQ:TNON) shares moved upwards by 7.61% to $0.23. The market value of their outstanding shares is at $4.8 million.
Losers
- Impel Pharmaceuticals (NASDAQ:IMPL) stock decreased by 33.3% to $0.72 during Tuesday's after-market session. The company's market cap stands at $17.0 million.
- Tempest Therapeutics (NASDAQ:TPST) shares fell 7.52% to $0.62. The market value of their outstanding shares is at $7.1 million. As per the press release, Q2 earnings came out 3 days ago.
- Eloxx Pharmaceuticals (NASDAQ:ELOX) stock decreased by 6.54% to $5.13. The company's market cap stands at $11.1 million.
- Aeglea BioTherapeutics (NASDAQ:AGLE) shares decreased by 5.99% to $0.44. The company's market cap stands at $42.8 million. As per the news, the Q2 earnings report came out 2 days ago.
- Kezar Life Sciences (NASDAQ:KZR) stock declined by 5.85% to $1.45. The market value of their outstanding shares is at $105.4 million. As per the press release, Q2 earnings came out 3 days ago.
- Cingulate (NASDAQ:CING) stock decreased by 5.67% to $0.58. This security traded at a volume of 108.6K shares come close, making up 26.2% of its average volume over the last 100 days. The company's market cap stands at $8.0 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.